Els Beirnaert

1.4k total citations
22 papers, 1.1k citations indexed

About

Els Beirnaert is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Els Beirnaert has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 11 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Els Beirnaert's work include HIV Research and Treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and HIV/AIDS drug development and treatment (7 papers). Els Beirnaert is often cited by papers focused on HIV Research and Treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and HIV/AIDS drug development and treatment (7 papers). Els Beirnaert collaborates with scholars based in Belgium, Netherlands and United Kingdom. Els Beirnaert's co-authors include Hans de Haard, Marc Lauwereys, Torsten Dreier, Pieter Rottiers, Peter Vanlandschoot, Karen Silence, Guido van der Groen, Wouter Janssens, Pieter Demetter and Lynn Huyck and has published in prestigious journals such as Journal of Virology, Frontiers in Immunology and Virology.

In The Last Decade

Els Beirnaert

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Els Beirnaert Belgium 13 527 488 363 253 238 22 1.1k
Urs Hoffmann Rohrer Switzerland 9 184 0.3× 343 0.7× 993 2.7× 214 0.8× 152 0.6× 9 1.5k
Kaustuv Banerjee United States 17 183 0.3× 560 1.1× 698 1.9× 228 0.9× 240 1.0× 20 1.5k
Roberto De Pascalis United States 18 207 0.4× 531 1.1× 721 2.0× 230 0.9× 101 0.4× 32 1.4k
Bernard de Geus Netherlands 11 759 1.4× 753 1.5× 424 1.2× 171 0.7× 29 0.1× 24 1.3k
Eiichi Okada Japan 14 225 0.4× 316 0.6× 528 1.5× 135 0.5× 160 0.7× 40 1.1k
Sergey Gorlatov United States 20 948 1.8× 813 1.7× 752 2.1× 576 2.3× 127 0.5× 30 2.4k
Ravi V. Kolla United States 14 132 0.3× 471 1.0× 495 1.4× 562 2.2× 96 0.4× 16 1.4k
Flavia Ferrantelli Italy 21 104 0.2× 574 1.2× 428 1.2× 345 1.4× 585 2.5× 46 1.2k
Pim Hermans Netherlands 16 620 1.2× 660 1.4× 238 0.7× 232 0.9× 23 0.1× 25 1.2k

Countries citing papers authored by Els Beirnaert

Since Specialization
Citations

This map shows the geographic impact of Els Beirnaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Beirnaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Beirnaert more than expected).

Fields of papers citing papers by Els Beirnaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els Beirnaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Beirnaert. The network helps show where Els Beirnaert may publish in the future.

Co-authorship network of co-authors of Els Beirnaert

This figure shows the co-authorship network connecting the top 25 collaborators of Els Beirnaert. A scholar is included among the top collaborators of Els Beirnaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els Beirnaert. Els Beirnaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beirnaert, Els, Aline Desmyter, Silvia Spinelli, et al.. (2017). Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions. Frontiers in Immunology. 8. 867–867. 63 indexed citations
2.
Roy, Maarten Van, Cedric Ververken, Els Beirnaert, et al.. (2015). The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 135–135. 145 indexed citations
3.
Vanlandschoot, Peter, Catelijne Stortelers, Els Beirnaert, et al.. (2011). Nanobodies®: New ammunition to battle viruses. Antiviral Research. 92(3). 389–407. 109 indexed citations
4.
Vandenbroucke, Klaas, Hans de Haard, Els Beirnaert, et al.. (2009). Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology. 3(1). 49–56. 222 indexed citations
5.
Forsman, Anna, Els Beirnaert, Marlén M. I. Aasa-Chapman, et al.. (2008). Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120. Journal of Virology. 82(24). 12069–12081. 91 indexed citations
6.
Steyaert, Sophia, Lieven Verhoye, Els Beirnaert, et al.. (2007). The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection. Journal of Immunological Methods. 320(1-2). 49–57. 2 indexed citations
7.
8.
Coppieters, Ken, Torsten Dreier, Karen Silence, et al.. (2006). Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis. Arthritis & Rheumatism. 54(6). 1856–1866. 239 indexed citations
9.
Janssens, Wouter, Carlo Boutton, Leo Heyndríckx, et al.. (2002). Comparison of Predicted Scaffold-Compatible Sequence Variation in the Triple-Hairpin Structure of Human Immunodeficiency Virus Type 1 gp41 with Patient Data. Journal of Virology. 76(15). 7595–7606. 4 indexed citations
10.
Beirnaert, Els, Sonia De Zutter, Wouter Janssens, & Guido van der Groen. (2001). Potent Broad Cross-Neutralizing Sera Inhibit Attachment of Primary HIV-1 Isolates (Groups M and O) to Peripheral Blood Mononuclear Cells. Virology. 281(2). 305–314. 15 indexed citations
11.
Vanham, Guido, Viggo Van Tendeloo, Betty Willems, et al.. (2000). The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells. Journal of Medical Virology. 60(3). 300–312. 5 indexed citations
12.
Beirnaert, Els, Phillipe N. Nyambi, Betty Willems, et al.. (2000). Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. Journal of Medical Virology. 62(1). 14–24. 42 indexed citations
13.
Beirnaert, Els, Phillipe N. Nyambi, Betty Willems, et al.. (2000). Identification and characterization of sera from HIV‐infected individuals with broad cross‐neutralizing activity against group M (env clade A–H) and group O primary HIV‐1 isolates. Journal of Medical Virology. 62(1). 14–24. 4 indexed citations
14.
Janssens, Wouter, John N. Nkengasong, Leo Heyndrickx, et al.. (1999). Intrapatient Variability of HIV Type 1 Group O ANT70 during a 10-Year Follow-up. AIDS Research and Human Retroviruses. 15(15). 1325–1332. 5 indexed citations
15.
Martinet, Wim, Tom Deroo, Xavier Saelens, et al.. (1998). Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A. Archives of Virology. 143(10). 2011–2019. 3 indexed citations
16.
17.
Vanlandschoot, Peter, Els Beirnaert, Johan Grooten, Willy Min Jou, & Walter Fiers. (1998). pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin. Archives of Virology. 143(2). 227–239. 6 indexed citations
18.
Beirnaert, Els, Betty Willems, Marc Peeters, et al.. (1998). Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. Journal of Virological Methods. 73(1). 65–70. 46 indexed citations
19.
Vanlandschoot, Peter, Els Beirnaert, Sabine Neirynck, et al.. (1996). Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells. Archives of Virology. 141(9). 1715–1726. 18 indexed citations
20.
Vanlandschoot, Peter, Els Beirnaert, Sylvia Dewilde, et al.. (1995). A Fairly Conserved Epitope on the Hemagglutinin of Influenza A (H3N2) Virus with Variable Accessibility to Neutralizing Antibody. Virology. 212(2). 526–534. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Urs Hoffmann Rohrer Breakdown of academic impact, for papers by Kaustuv Banerjee Breakdown of academic impact, for papers by Roberto De Pascalis Breakdown of academic impact, for papers by Bernard de Geus Breakdown of academic impact, for papers by Eiichi Okada Breakdown of academic impact, for papers by Sergey Gorlatov Breakdown of academic impact, for papers by Ravi V. Kolla Breakdown of academic impact, for papers by Flavia Ferrantelli Breakdown of academic impact, for papers by Pim Hermans
Rankless by CCL
2026